Psychotic States brings together a number of the author's papers written between 1946 and 1964 dealing with the psychopathology and treatment of various psychotic and borderline conditions from a psychoanalytic viewpoint. Taking the theories and techniques developed by Melanie Klein in her work with infants and young children, the author investigated their application to a range of psychotic syndromes, including chronic and acute schizophrenia, severe hypochondriasis, drug addiction, severe depression and manic depression, both to determine their possible therapeutic efficacy and to see what light they might shed on the etiology of the psychosis.

Creativity and Psychotic States in Exceptional People tells the story of the lives of four exceptionally gifted individuals: Vincent van Gogh, Vaslav Nijinsky, José Saramago and John Nash. Previously unpublished chapters by Murray Jackson are set in a contextual framework by Jeanne Magagna, revealing the wellspring of creativity in the subjects’ emotional experiences and delving into the nature of psychotic states which influence and impede the creative process. Jackson and Magagna aim to illustrate how psychoanalytic thinking can be relevant to people suffering from psychotic states of mind and provide understanding of the personalities of four exceptionally talented creative individuals. Present in the text are themes of loving and losing, mourning and manic states, creating as a process of repairing a sense of internal damage and the use of creativity to understand or run away from oneself. The book concludes with a glossary of useful psychoanalytic concepts. Creativity and Psychotic States in Exceptional People will be fascinating reading for psychiatrists, psychotherapists and psychoanalysts, other psychoanalytically informed professionals, students and anyone interested in the relationship between creativity and psychosis.

“This brilliant and beautifully written book invokes a radical reorientation of the treatment of psychosis” Juliet Flower MacCannell, Author of Figuring Lacan and The Hysteric’s Guide to the Future Female Subject. “Bret Fimiani's book offers an illuminating presentation of the Lacanian approach to psychosis thanks to his clear style which presents Lacanian concepts with a wonderful accuracy, illustrated by examples from his psychoanalytic practice. The dynamic of his investigation challenges the fear of psychosis with testimonies of lived experiences, the Hearing Voices Network, and analysts who claim the unclaimed intelligence at work in psychosis." Francoise Davoine, co-author of History Beyond Trauma This book advances a theory of transference-in-psychosis with the aim of provoking a change in the way the experience of psychosis is understood and thus, clinically treated. It examines the function of ‘ethics’ in the ‘installation’ of transference in the treatment of psychosis and contends that the aim of the psychoanalytic experience is the creation of a new ethic for the analysand and for the treatment. Beginning from the premise that the body of the psychotic is a site of social contestation, the author draws upon the work of Freud, Lacan, Deleuze & Guattari and Apollon to reframe the problem of the ‘body’ (as an effect of language) and its relation to transference, and ethics, in treating psychosis. It argues that psychosis still has much to teach psychoanalysis about how psychoanalysis must continue to change in order to create/offer an approach that is effective for psychosis (versus neurosis) and provides a comprehensive psychoanalytic theory of psychosis that derives, at its core, from the experience of psychosis itself. The book’s synthesis of clinical and ‘peer model’ principles will provide readers with a way to understand and navigate potential transference impasses often encountered with purely clinical approaches. In doing so it provides a valuable new framework for practitioners and scholars working in clinical psychology, psychoanalysis, philosophy, critical theory, psychiatry and social work.

This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.

This book explains the ideas to be found in the interface between psychoanalysis, psychiatry and other disciplines.

The new edition of this popular handbook has been thoroughly updated to include the latest data concerning treatment of first-episode patients. Drawing from their experience, the authors discuss the presentation and assessment of the first psychotic episode and review the appropriate use of antipsychotic agents and psychosocial approaches in effective management. This is an authoritative text written by a team of highly respected authors for psychiatrists, neurologists, primary care practitioners and health care professional working in psychiatry. Drawing from their experience, the presentation and assessment of the first psychotic episode are discussed, details regarding antipsychotic drugs and their appropriate use are reviewed and psychosocial approaches are examined. The resulting book offers a concise and valuable guide to those wishing to review the latest proposals for the treatment of first-episode psychosis supported by up-to-date references, in a single publication.

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.